oxelumab (103)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLLESGGG LVQPGGSLRL SCAASGFTFN SYAMSWVRQA PGKGLEWVSI  50

ISGSGGFTYY ADSVKGRFTI SRDNSRTTLY LQMNSLRAED TAVYYCAKDR 100

LVAPGTFDYW GQGALVTVSS ASTKGPSVFP LAPSSKSTSG GTAALGCLVK 150

DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT 200

YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP 250

KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN 300

STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ 350

VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV 400

LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPG  449

Light chain / Chaone lygire / Cadena ligera

DIQMTQSPSS LSASVGDRVT ITCRASQGIS SWLAWYQQKP EKAPKSLIYA  50

ASSLQSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YNSYPYTFGQ 100

GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV 150

DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG 200

LSSPVTKSFN RGEC                                        214

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	147-203	264-324	370-428

	22??-96??	147??-203??	264??-324??	370??-428??

Intra-L	23?-88?	134?-194?



	23???-88???	134???-194???



Inter-H-L	223-214?	223??-214???



Inter-H-H	229-229??	232-232??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

300, 300??

CAS		89957-37-9 

Description

immunoglobulin G1-kappa, anti-[Homo sapiens TNFSF4 (Tumor necrosis
factor ligand superfamily member 4, OX40 ligand, OX-40L, TAX
transcriptionally-activated glycoprotein 1, TXGP1, gp34, CD252], Homo
sapiens monoclonal antibody;

gamma1 heavy chain (1-449) [Homo sapiens VH (IGHV3-23*01 (94.90%)
-(IGHD)-IGHJ4*01 T122>A) [8.8.13] (1-120) -IGHG1*01 K130>del (121-449)],
(223-214?)-disulfide with kappa light chain (1?-214?) [Homo sapiens
V-KAPPA (IGKV1D-16*01 (100.00%) -IGKJ2*01) [6.3.9] (1?-107?) -IGKC*01
(108?-214?)]; (229-229??:232-232??)-bisdisulfide dimer

immunoglobuline G1-kappa, anti-[Homo sapiens TNFSF4 (membre 4 de la
superfamille des ligands du facteur de nycrose tumorale, ligand de OX40,
OX40L, glycoprotyine 1 activye transcriptionellement par TAX, TXGP1,
CD252], Homo sapiens anticorps monoclonal;

chaone lourde gamma1 (1-449) [Homo sapiens VH (IGHV3-23*01 (94.90%)
-(IGHD)-IGHJ4*01 T122>A) [8.8.13] (1-120) -IGHG1*01 K130>del (121-449)],
(223-214?)-disulfure avec la chaone lygire kappa (1?-214?) [Homo sapiens
V-KAPPA (IGKV1D-16*01 (100.00%) -IGKJ2*01) [6.3.9] (1?-107?) -IGKC*01
(108?-214?)]; dimire (229-229??:232-232??)-bisdisulfure 

inmunoglobulina G1-kappa, anti-[Homo sapiens TNFSF4 (miembro 4 de la
superfamilia de ligandos del factor de necrosis tumoral, ligando de
OX40, OX40L, glicoprotenna 1 activada por transcripciun por

TAX, TXGP1, CD252 ], anticuerpo monoclonal de Homo sapiens;

cadena pesada gamma1 (1-449) [Homo sapiens VH (IGHV3-23*01 (94.90%)
-(IGHD)-IGHJ4*01 T122>A) [8.8.13] (1-120) -IGHG1*01 K130>del (121-449)],
(223-214?)-disulfuro con la cadena ligera

kappa (1?-214?) [Homo sapiens V-KAPPA (IGKV1D-16*01 (100.00%) -IGKJ2*01)
[6.3.9] (1?-107?) -IGKC*01 (108?-214?)]; dimero
(229-229??:232-232??)-bisdisulfuro

	

WHO 

International Nonproprietary Names Programme	

30/062010

9320

		

